Year: 2022
-
Most COVID-19 ‘Long Haulers’ Continue to Experience Symptoms 15 Months After Initial Infection
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
-
Honoring the MD Class of 2022
Feinberg honored the MD Class of 2022 during the medical school’s 163rd commencement ceremony in the Aon Grand Ballroom at Navy Pier, held in person for the first time since 2019.
-
Gradishar Receives 2022 Rodger Winn Award
William Gradishar, MD, chief of Hematology and Oncology in the Department of Medicine and deputy director of the clinical network of the Lurie Cancer Center, has received the 2022 Rodger Winn Award from the National Comprehensive Cancer Network.
-
Celebrating Honors Day 2022
Dozens of faculty members and fourth-year medical students were recognized for their scholarly and clinical excellence at Feinberg’s Honors Day, held May 20.
-
Blood Test Predicts Response to Immunotherapy
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
-
Study Identifies New Therapeutic Target for Most Common Type of Pancreatic Cancer
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
-
Morhardt Appointed to Illinois Supreme Court Commission on Elder Law
Darby Morhardt, PhD, LCSW, research professor in the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease and of Preventive Medicine in the Division of Public Health Practice, was recently appointed to the Illinois Supreme Court Commission on Elder Law.
-
Student Investigates Private Equity in Dermatology
Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.
-
Recurring Brain Tumor Growth is Halted with New Drug
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
-
New Regulator of Therapy Resistance in Prostate Cancer
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
